ArticleJournal of the American College of Cardiology2022
Trends in Clinical Presentation, Management, and Outcomes of STEMI in Patients With COVID-19.
Article in Journal of the American College of Cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 26 citations in OpenAlex.
- Persistent One-Year Mortality Gradient After STEMI and COVID-19: Long-Term Outcomes From the NACMI Registry.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
- Angiographic and Electrocardiographic Characteristics of Patients With Non-ST-Segment Elevation Myocardial Infarction and COVID-19.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
- Baseline ECG Outperforms the Angiogram for Predicting Mortality in COVID-19-Associated STEMI: Insights From the NACMI Registry.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
- Impact of a 24/7 on-site percutaneous coronary intervention team strategy on door-to-wire time.BMJ open quality · 2025Article
- Trends and Outcomes of Acute Myocardial Infarction During the Early COVID-19 Pandemic in the United States: A National Inpatient Sample Study.Korean circulation journal · 2024Article
- Evolving Clinical Manifestations and Outcomes in COVID-19 Patients: A Comparative Analysis of SARS-CoV-2 Variant Waves in a Romanian Hospital Setting.Pathogens (Basel, Switzerland) · 2023Article
- Primary PCI, Thrombus, and COVID-19: Remembrance of Things Past.Journal of the American College of Cardiology · 2023Article
- Thrombus Burden and Outcomes in Patients With COVID-19 Presenting With STEMI Across the Pandemic.Journal of the American College of Cardiology · 2023Observational
- Comparative Analysis of Patients With STEMI and COVID-19 Between Canada and the United States.Journal of the Society for Cardiovascular Angiography & Interventions · 2023Article
- The impact of the coronavirus pandemic on patients hospitalized due to acute coronary syndrome.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2023Review
- Clinical characteristics of COVID-19 associated vasculopathic diseases.Thrombosis journal · 2023Review
- Interaction of COVID-19 With Common Cardiovascular Disorders.Circulation research · 2023Review
- A Review of Heart Failure in Patients with COVID-19.Heart failure clinics · 2023Review
- Excess cardiovascular mortality across multiple COVID-19 waves in the United States from March 2020 to March 2022.Nature cardiovascular research · 2023Article
- [Acute coronary syndromes and COVID-19: An informative imbalance].Archives des maladies du coeur et des vaisseaux. Pratique · 2022Review
- Updates on the Management of STEMI in 2021: Beyond COVID-19.Journal of the American College of Cardiology · 2022Article
- Temporal trends in cardiovascular care: Insights from the COVID-19 pandemic.Frontiers in cardiovascular medicine · 2022Review
- STEMIs and a Closer Look at MINOCA During the COVID-19 Pandemic.Journal of the Society for Cardiovascular Angiography & InterventionsArticle
Corrections and comments
- Commented on by
Authors and funding
27 authors at 19 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe previously reported high in-hospital mortality for ST-segment elevation myocardial infarction (STEMI) patients with COVID-19 treated in the early phase of the pandemic.
objectivesThe purpose of this study was to describe trends of COVID-19 patients with STEMI during the course of the pandemic.
methodsThe NACMI (North American COVID-19 STEMI) registry is a prospective, investigator-initiated, multicenter, observational registry of hospitalized STEMI patients with confirmed or suspected COVID-19 infection in North America. We compared trends in clinical characteristics, management, and outcomes of patients treated in the first year of the pandemic (January 2020 to December 2020) vs those treated in the second year (January 2021 to December 2021).
resultsA total of 586 COVID-19-positive patients with STEMI were included in the present analysis; 227 treated in Y2020 and 359 treated in Y2021. Patients' characteristics changed over time. Relative to Y2020, the proportion of Caucasian patients was higher (58% vs 39%; P < 0.001), patients presented more frequently with typical ischemic symptoms (59% vs 51%; P = 0.04), and patients were less likely to have shock pre-PCI (13% vs 18%; P = 0.07) or pulmonary manifestations (33% vs. 47%; P = 0.001) in Y2021. In-hospital mortality decreased from 33% (Y2020) to 23% (Y2021) (P = 0.008). In Y2021, none of the 22 vaccinated patients expired in hospital, whereas in-hospital death was recorded in 37 (22%) unvaccinated patients (P = 0.009).
conclusionsSignificant changes have occurred in the clinical characteristics and outcomes of STEMI patients with COVID-19 infection during the course of the pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.